Page 132 - 《中国药房》2023年2期
P. 132

vascular  dysfunction  in  pulmonary  hypertension  and  im‐  files in Wistar rats[J]. PeerJ,2018,6:e6110.
               plications for novel therapies[J]. Am J Physiol Heart Circ   [34]  李敏,张乐曙,周洁茹,等. 青蒿素和胺碘酮对大鼠心律
               Physiol,2022,322(5):H702-H724.                      失 常 作 用 的 对 比 研 究 [J].  重 庆 医 学 ,2020,49(6):
          [21]  BAO C L,HE Q,WANG H,et al. Artemisinin and its deri‐  883-886.
               vate  alleviate  pulmonary  hypertension  and  vasoconstric‐  [35]  范铁兵,李运伦,丁书文. 丁书文运用青蒿、常山治疗心
               tion  in  rodent  models[J].  Oxid  Med  Cell  Longev,2022,  律失常的研究[J]. 国医论坛,2020,35(1):52-54.
               2022:2782429.                                  [36]  袁向科,江瑞. 青蒿素对氧化低密度脂蛋白诱导的血管
          [22]  TANG M,WANG R Y,FENG P P,et al. Dihydroartemi-     内皮细胞损伤的作用及机制[J]. 解放军医学杂志,2021,
               sinin  attenuates  pulmonary  hypertension  through  inhibi‐  46(4):333-339.
               tion of pulmonary vascular remodeling in rats[J]. J Cardio‐  [37]  WANG P,TIAN X Y,TANG J X,et al. Artemisinin pro‐
               vasc Pharmacol,2020,76(3):337-348.                  tects endothelial function and vasodilation from oxidative
          [23]  CAI H J,FAN S Q,CAI L Q,et al. Dihydroartemisinin     damage  via  activation  of  PI3K/Akt/eNOS  pathway[J].
               attenuates hypoxia-induced pulmonary hypertension through   Exp Gerontol,2021,147:111270.
               the  ELAVL2/miR-503/PI3K/Akt  axis[J].  J  Cardiovasc   [38]  LI R,YIN H L,WANG J,et al. Dihydroartemisinin alle-
               Pharmacol,2022,80(1):95-109.                        viates  skin  fibrosis  and  endothelial  dysfunction  in
          [24]  LI Y Z,CAI H J,WEI J Q,et al. Dihydroartemisinin at‐  bleomycin-induced skin fibrosis models[J]. Clin Rheuma‐
               tenuates  hypoxic  pulmonary  hypertension  via  the  down‐  tol,2021,40(10):4269-4277.
               regulation  of  miR-335  targeting  Vangl2[J].  DNA  Cell   [39]  YANG B Q,GAO X L,SUN Y C,et al. Dihydroartemi-
               Biol,2022,41(8):750-767.                            sinin  alleviates  high  glucose-induced  vascular  smooth
          [25]  HUO Y B,GAO X,PENG Q,et al. Dihydroartemisinin al‐  muscle cells proliferation and inflammation by depressing
               leviates AngⅡ-induced vascular smooth muscle cell proli-  the  miR-376b-3p/KLF15  pathway[J].  Biochem  Biophys
               feration and inflammatory response by blocking the FTO/  Res Commun,2020,530(3):574-580.
               NR4A3 axis[J]. Inflamm Res,2022,71(2):243-253.  [40]  JIANG Y Y,SHUI J C,ZHANG B X,et al. The potential
          [26]  LIU  X  X,WANG  X  X,PAN  Y,et  al. Artemisinin  im‐  roles of artemisinin and its derivatives in the treatment of
               proves  acetylcholine-induced  vasodilatation  in  rats  with   type  2  diabetes  mellitus[J].  Front  Pharmacol,2020,11:
               primary  hypertension[J]. Drug  Des  Dev  Ther,2021,15:  585487.
               4489-4502.                                     [41]  CHEN Y,LI W,NONG X L,et al. Role of artesunate on
          [27]  XU W X,LU C F,ZHANG F,et al. Dihydroartemisinin    cardiovascular complications in rats with type 1 diabetes
               counteracts  fibrotic  portal  hypertension  via  farnesoid  X   mellitus[J]. BMC Endocr Disord,2021,21(1):19.
               receptor-dependent inhibition of hepatic stellate cell con‐  [42]  李亚云,宗刚军,黄月皎. 青蒿素对心肌梗死大鼠心肌损
               traction[J]. FEBS J,2017,284(1):114-133.            伤及TLR4/MyD88/NF-κB p65信号通路的影响[J]. 中国
          [28]  宋爱新,王璐,张媛媛. 青蒿素对心肌梗死大鼠心室重构                         煤炭工业医学杂志,2021,24(3):225-230.
               的作用研究[J]. 中国临床药理学杂志,2020,36(10):               [43]  崔勤涛,王学惠,刘永强,等. 双氢青蒿素通过抑制蛋白
               1233-1236.                                          激酶 B 和 NF-κB p65 磷酸化减轻缺血再灌注导致的小
          [29]  REID B G,STRATTON M S,BOWERS S,et al. Disco-       鼠心肌损伤[J]. 中国药理学与毒理学杂志,2021,35(4):
               very of novel small molecule inhibitors of cardiac hyper‐  259-264.
               trophy  using  high  throughput,high  content  imaging[J].  J   [44]  KHAN A I,KAPOOR A,CHEN J M,et al. The antima‐
               Mol Cell Cardiol,2016,97:106-113.                   larial drug artesunate attenuates cardiac injury in a rodent
          [30]  GU Y  W,WANG  X,WANG  X,et  al. Artemisinin  atte-    model of myocardial infarction[J]. Shock,2018,49(6):
               nuates  post-infarct  myocardial  remodeling  by  down-  675-681.
               regulating  the  NF- κB  pathway[J].  Tohoku  J  Exp  Med,  [45]  CHEN Y Y,ZHENG S H,WANG Z W,et al. Artesunate
               2012,227(3):161-170.                                restrains  maturation  of  dendritic  cells  and  ameliorates
          [31]  史钰芳,杨靖,苗思露. 青蒿素对心衰兔心功能及窦房结                         heart  transplantation-induced  acute  rejection  in  mice
               功能的影响[J]. 中国中医药科技,2020,27(1):31-34.                 through the PERK/ATF4/CHOP signaling pathway[J]. Me‐
          [32]  GU Y W,WU  G,WANG  X,et  al. Artemisinin  prevents   diators Inflamm,2021,2021:2481907.
               electric remodeling following myocardial infarction possi‐  [46]  YOON  S  S,KWON  H  W,SHIN  J  H,et  al.  Anti-
               bly by upregulating the expression of connexin 43[J]. Mol   thrombotic  effects  of  artesunate  through  regulation  of
               Med Rep,2014,10(4):1851-1856.                       cAMP  and  PI3K/MAPK  pathway  on  human  platelets[J].
          [33]  XU X,ZHANG Q,SONG H Q,et al. Effects of artemi-    Int J Mol Sci,2022,23(3):1586.
               sinin  on  ventricular  arrhythmias  in  response  to  left  ven‐  (收稿日期:2022-09-05  修回日期:2022-12-24)
               tricular afterload increase and microRNA expression pro‐                           (编辑:邹丽娟)





          · 250 ·    China Pharmacy  2023 Vol. 34  No. 2                               中国药房  2023年第34卷第2期
   127   128   129   130   131   132   133   134   135   136   137